公开(公告)号：US20210333291A1

公开(公告)日：2021-10-28

申请号：US17370180

申请日：2021-07-08

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Uwe KOBOLD ,  Andreas LEINENBACH ,  Indranil MITRA ,  Holger BUSSKAMP

IPC: G01N33/72 ,  G01N33/68

Abstract: The present invention refers to a method for determining intact glycated hemoglobin A (HbA1c) by mass spectrometry (MS), a kit and a diagnostic system adapted for performing the method.

公开(公告)号：US20210333290A1

公开(公告)日：2021-10-28

申请号：US17370170

申请日：2021-07-08

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Uwe KOBOLD ,  Andreas LEINENBACH ,  Indranil MITRA

IPC: G01N33/72 ,  G01N33/68

Abstract: The present invention refers to a method for determining peptide fragments of glycated hemoglobin A (HbA1c) molecules by mass spectrometry (MS), a reagent kit, and a clinical diagnostic system adapted for performing the method.